Received Mar 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
COVID again; COVID again; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A 71-year-old male patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "medical conditions" (ongoing); "COVID-19" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Paxlovid for COVID-19 treatment. Vaccination history included: Comirnaty (DOSE 1), for COVID-19 immunization; Comirnaty (DOSE 2), for COVID-19 immunization; Comirnaty (DOSE NUMBER UNKNOWN (BOOSTER)), for COVID-19 immunization. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "COVID again". The clinical course was reported as follows: An elder patient with medical conditions mentioned, had been getting the Pfizer COVID vaccinations every year since they were released. The patient had COVID previously, despite the vaccine. The patient reported had COVID again and was prescribed nirmatrelvir/ritonavir. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.
Ill-defined disorder NOS
Medical History/Concurrent Conditions: COVID-19